0001209191-22-052216.txt : 20221004 0001209191-22-052216.hdr.sgml : 20221004 20221004162442 ACCESSION NUMBER: 0001209191-22-052216 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221004 DATE AS OF CHANGE: 20221004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Tom Y CENTRAL INDEX KEY: 0001623609 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14468 FILM NUMBER: 221291971 MAIL ADDRESS: STREET 1: 1807 SAN GABRIEL BLVD. CITY: SAN GABRIEL STATE: CA ZIP: 91776 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PURE BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001006028 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 330530289 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 9669 HERMOSA AVENUE CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 619-596-8600 MAIL ADDRESS: STREET 1: 9669 HERMOSA AVENUE CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCE DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCES DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES DATE OF NAME CHANGE: 19960122 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-30 0 0001006028 PURE BIOSCIENCE, INC. PURE 0001623609 Lee Tom Y 1807 SAN GABRIEL BLVD. SAN GABRIEL CA 91776 1 1 1 0 Chief Executive Officer Stock Option (Right to Buy) 0.20 2022-09-30 4 A 0 125000 0.00 A 2032-09-30 Common Stock 125000 125000 D Stock Option (Right to Buy) 0.20 2022-09-30 4 A 0 200000 0.00 A 2032-09-30 Common Stock 200000 200000 D The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024. The option shares shall vest and become exercisable in four equal installments December 30, 2022, March 30, 2023, June 30, 2023, and September 30, 2023. /s/ Tom Lee 2022-10-04